ENGN
enGene Holdings Inc.
NASDAQ · Healthcare · Biotechnology · CA
$1.82
−0.55%Next report
Analyst consensus
- Next report date
- Sep 14, 2026
- EPS estimate
- -$0.47
- Revenue estimate
- —
Latest reported
- Last report date
- Jun 15, 2026
- EPS actual
- -$0.43
- EPS estimate
- -$0.48
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +0.1%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $4.00
- PT range
- $4.00 – $4.00
- Analysts
- 2
1 Buy0 Hold1 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Sep 14, 2026